全文获取类型
收费全文 | 30898篇 |
免费 | 2694篇 |
国内免费 | 1378篇 |
专业分类
耳鼻咽喉 | 134篇 |
儿科学 | 388篇 |
妇产科学 | 1133篇 |
基础医学 | 2898篇 |
口腔科学 | 327篇 |
临床医学 | 3191篇 |
内科学 | 4786篇 |
皮肤病学 | 422篇 |
神经病学 | 1689篇 |
特种医学 | 1256篇 |
外国民族医学 | 11篇 |
外科学 | 4615篇 |
综合类 | 5789篇 |
现状与发展 | 7篇 |
预防医学 | 765篇 |
眼科学 | 1234篇 |
药学 | 2951篇 |
18篇 | |
中国医学 | 1812篇 |
肿瘤学 | 1544篇 |
出版年
2024年 | 40篇 |
2023年 | 479篇 |
2022年 | 614篇 |
2021年 | 1109篇 |
2020年 | 1187篇 |
2019年 | 1064篇 |
2018年 | 1012篇 |
2017年 | 1062篇 |
2016年 | 1105篇 |
2015年 | 1218篇 |
2014年 | 1995篇 |
2013年 | 2216篇 |
2012年 | 1810篇 |
2011年 | 2008篇 |
2010年 | 1725篇 |
2009年 | 1600篇 |
2008年 | 1674篇 |
2007年 | 1710篇 |
2006年 | 1631篇 |
2005年 | 1438篇 |
2004年 | 1236篇 |
2003年 | 1060篇 |
2002年 | 906篇 |
2001年 | 740篇 |
2000年 | 642篇 |
1999年 | 492篇 |
1998年 | 415篇 |
1997年 | 355篇 |
1996年 | 291篇 |
1995年 | 285篇 |
1994年 | 223篇 |
1993年 | 184篇 |
1992年 | 184篇 |
1991年 | 180篇 |
1990年 | 119篇 |
1989年 | 108篇 |
1988年 | 102篇 |
1987年 | 103篇 |
1986年 | 81篇 |
1985年 | 112篇 |
1984年 | 80篇 |
1983年 | 52篇 |
1982年 | 59篇 |
1981年 | 77篇 |
1980年 | 44篇 |
1979年 | 39篇 |
1978年 | 31篇 |
1977年 | 21篇 |
1976年 | 15篇 |
1975年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 203 毫秒
1.
2.
3.
Wojciech Szychta M.D. Ph.D. Gheorghe Cerin M.D. Ph.D. F.E.S.C. Bogdan Adrian Popa M.D. Armienti Felice M.D. Guido Lanzillo M.D. Ph.D. Marco Diena M.D. Grzegorz Opolski M.D. Ph.D. F.E.S.C. 《Echocardiography (Mount Kisco, N.Y.)》2015,32(6):1040-1043
Sinus venosus atrial septal defect (SV‐ASD) usually coexists with partial anomalous pulmonary vein connection (PAPVC). It is a difficult diagnosis in transthoracic echocardiography (TTE) due to eccentric position of defects. We present a rare case of atypical anatomical variation in PAPVC, which was never described before. Two right pulmonary veins drained into superior vena cava, which overrode SV‐ASD and interatrial septum, a third pulmonary vein into the right atrium. Complete diagnosis could not be set after TTE, nor transesophageal echocardiography, whereas angio‐CT was finally conclusive. This diagnostic approach allowed the surgical planning. 相似文献
4.
5.
《Archives of Cardiovascular Diseases》2022,115(10):505-513
Central illustration: cumulative major adverse cardiac events (MACE) and bioresorbable vascular scaffold (BVS) thrombosis rates after 1, 2, 3, 4 and 5 years. 相似文献
6.
7.
由于骨盆的特殊结构,其内侧的血管网损伤导致不可压迫性出血。即使创伤中心和救治体系的建设,以及损害控制技术等发展,病死率仍然高达30%~60%。损害控制性复苏、骨盆带、外固定支架、复苏性腹主动脉内球囊阻断(REBOA)、动脉栓塞和腹膜外填塞等技术不断发展,部分已经得到普及,但迄今仍没有公认的确定性止血流程。我国正在普遍建设创伤中心,亟待制订适合我国的骨盆骨折大出血患者的救治流程,以提高救治成功率。本文阐述控制骨盆骨折大出血的外科技术和流程进展供同道参考。 相似文献
8.
9.
Purpose: To describe how central venous access devices (CVADs) are utilized for ambulatory oncology patients and to evaluate the rate of complications. Method: Single institution retrospective study of oncology patients with CVADs who received systemic treatment at the Walker Family Cancer Centre (WFCC) between 1 January and 31 December 2018. Results: A total of 480 CVADS were placed in 305 patients, of which 408 (85%) were peripherally inserted central catheters (PICCs) and 72 (15%) were implanted vascular access devices (PORTs). The incidence of early and late complications was 9% and 24%, respectively. For the entire cohort, the rate of venous thromboembolism (VTE) was 16%, of which 9% were CVAD-related thrombosis (CRTs) and 7% were distant VTE. The CRT rates were similar for PICCs and PORTs (9% vs. 7%). A total of 6% of CVADs were complicated by infection (i.e., localized infections and bacteremia), with a total infection rate of 0.43 and 0.26 per 1000 indwelling days for PICCs and PORTs, respectively. The incidence of central line associated bloodstream infections (CLABSI) was greater for PICCs than PORTs, at a rate of 0.22 compared with 0.08 per 1000 indwelling days, respectively. The premature catheter removal rate was 26% for PICCs and 18% for PORTs. PORTs required more additional hospital visits. Conclusions: PICCs were utilized more frequently than PORTs and had a higher rate of premature removal. The rates of VTE and CRT were similar for both CVAD types. PORTs had a lower rate of infection per 1000 indwelling days. However, the management of PORT related complications required more visits to the hospital and oncology clinic. 相似文献
10.
Melatonin reduces oxidative stress and improves vascular function in pulmonary hypertensive newborn sheep 下载免费PDF全文
Flavio Torres Alejandro González‐Candia Camilo Montt Germán Ebensperger Magdalena Chubretovic María Serón‐Ferré Roberto V. Reyes Aníbal J. Llanos Emilio A. Herrera 《Journal of pineal research》2015,58(3):362-373
Pulmonary hypertension of the newborn (PHN) constitutes a critical condition with severe cardiovascular and neurological consequences. One of its main causes is hypoxia during gestation, and thus, it is a public health concern in populations living above 2500 m. Although some mechanisms are recognized, the pathophysiological facts that lead to PHN are not fully understood, which explains the lack of an effective treatment. Oxidative stress is one of the proposed mechanisms inducing pulmonary vascular dysfunction and PHN. Therefore, we assessed whether melatonin, a potent antioxidant, improves pulmonary vascular function. Twelve newborn sheep were gestated, born, and raised at 3600 meters. At 3 days old, lambs were catheterized and daily cardiovascular measurements were recorded. Lambs were divided into two groups, one received daily vehicle as control and another received daily melatonin (1 mg/kg/d), for 8 days. At 11 days old, lung tissue and small pulmonary arteries (SPA) were collected. Melatonin decreased pulmonary pressure and resistance for the first 3 days of treatment. Further, melatonin significantly improved the vasodilator function of SPA, enhancing the endothelial‐ and muscular‐dependent pathways. This was associated with an enhanced nitric oxide‐dependent and nitric oxide independent vasodilator components and with increased nitric oxide bioavailability in lung tissue. Further, melatonin reduced the pulmonary oxidative stress markers and increased enzymatic and nonenzymatic antioxidant capacity. Finally, these effects were associated with an increase of lumen diameter and a mild decrease in the wall of the pulmonary arteries. These outcomes support the use of melatonin as an adjuvant in the treatment for PHN. 相似文献